AnalystsJonathan MillerJonathan Miller's Stock Forecasts
AnalystsJonathan Miller
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4035 out of 4586 analysts
Average Return
-37.71%
Win Rate
17%1 out of 6
Risk vs Reward
Poor
Good
Jonathan Miller's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gamida Cell LtdGMDAQ | +41.85% | $4.54 | $6.44 | 2020-06-30 - 2021-07-01 | Buy |
Jonathan Miller Analyst Color
Get additional color on Jonathan Miller's coverage of popular stocks
Jonathan Miller's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prokidney CorpPROK | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Vaxxinity IncVAXX | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Shattuck Labs IncSTTK | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Sqz Biotechnologies CoSQZB | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Nanobiotix SaNBTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.